Skip to main content
SpringerLink
Log in

Adolescent Pregnancy and Contraception

  • Chapter
  • First Online:
Frontiers in Gynecological Endocrinology

Part of the book series: ISGE Series ((ISGE))

Abstract

Adolescent pregnancy is defined as a pregnancy in an adolescent girl, usually within the ages of 13–19.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 64.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. WHO publication, Adolescent pregnancy. 2012

    Google Scholar 

  2. Chibber R, Fouda M, Al-Hijji J et al (2014) Adverse pregnancy outcome among teenagers: a reality? J Obstetr Gynaecol J Inst Obstetr Gynaecol 34(4):297–300

    Article  CAS  Google Scholar 

  3. WHO Publication, adolescent pregnancy, Fact sheet N°364. Sept 2014

    Google Scholar 

  4. Nelson AI, Neinstein LS (2009) Contraception. In: Neinstein LS, Gordon CM, Katzman DK (eds) Handbook of adolescent health care. Lippincott Williams & Wilkins, Philadelphia, p 389

    Google Scholar 

  5. Secura GM, Madden T, McNicholas C et al (2014) Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med 371(14):1316–1323

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Sanfilippo JS (1991) Adolescents and oral contraceptives. Int J Fertil 36(Suppl 2):65–77; discussion 77–69

    PubMed  Google Scholar 

  7. Braverman PK, Breech L, Committee on Adolescence, American Academy of Pediatrics (2010) Clinical report – gynecologic examination for adolescents in the pediatric office setting. Pediatrics 126(3):583–590

    Article  PubMed  Google Scholar 

  8. (2005) ‘Black box’ warning added to contraceptive injection. FDA Consum. 39(2):3

    Google Scholar 

  9. Cromer BA, Scholes D, Berenson A et al (2006) Depot medroxyprogesterone acetate and bone mineral density in adolescents –the black box warning: a position paper of the society for adolescent medicine. J Adolesc Health 39(2):296–301

    Article  PubMed  Google Scholar 

  10. Vandenbroucke JP, Rosing J, Bloemenkamp KW et al (2001) Oral contraceptives and the risk of venous thrombosis. N Engl J Med 344(20):1527–1535

    Article  CAS  PubMed  Google Scholar 

  11. Douketis JD, Ginsberg JS, Holbrook A, Crowther M, Duku EK, Burrows RF (1997) A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy. Arch Intern Med 157(14):1522–1530

    Article  CAS  PubMed  Google Scholar 

  12. Bloemenkamp KW, Rosendaal FR, Buller HR, Helmerhorst FM, Colly LP, Vandenbroucke JP (1999) Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med 159(1):65–70

    Article  CAS  PubMed  Google Scholar 

  13. PhVWP Monthly report on safety concerns, guidelines and general matters. European Medicines Agency; Jan 2012

    Google Scholar 

  14. Rosing J, Tans G, Nicolaes GA et al (1997) Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. Br J Haematol 97(1):233–238

    Article  CAS  PubMed  Google Scholar 

  15. Rosing J, Middeldorp S, Curvers J et al (1999) Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. Lancet 354(9195):2036–2040

    Article  CAS  PubMed  Google Scholar 

  16. Middeldorp S, Meijers JC, van den Ende AE et al (2000) Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study. Thromb Haemost 84(1):4–8

    CAS  PubMed  Google Scholar 

  17. Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE (2002) Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation. Thromb Haemost 87(2):199–205

    CAS  PubMed  Google Scholar 

  18. Kemmeren JM, Algra A, Meijers JC et al (2004) Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial. Blood 103(3):927–933

    Article  CAS  PubMed  Google Scholar 

  19. Sidney S, Petitti DB, Soff GA, Cundiff DL, Tolan KK, Quesenberry CP Jr (2004) Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives. Contraception 70(1):3–10

    Article  CAS  PubMed  Google Scholar 

  20. Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ (2007) Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 139(2):289–296

    Article  PubMed  Google Scholar 

  21. Abdollahi M, Cushman M, Rosendaal FR (2003) Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost 89(3):493–498

    CAS  PubMed  Google Scholar 

  22. Nightingale AL, Lawrenson RA, Simpson EL, Williams TJ, MacRae KD, Farmer RD (2000) The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives. Eur J Contracept Reprod Health Care 5(4):265–274

    Article  CAS  PubMed  Google Scholar 

  23. Louv WC, Austin H, Perlman J, Alexander WJ (1989) Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol 160(2):396–402

    Article  CAS  PubMed  Google Scholar 

  24. Rubin GL, Ory HW, Layde PM (1982) Oral contraceptives and pelvic inflammatory disease. Am J Obstet Gynecol 144(6):630–635

    Article  CAS  PubMed  Google Scholar 

  25. Ness RB, Keder LM, Soper DE et al (1997) Oral contraception and the recognition of endometritis. Am J Obstet Gynecol 176(3):580–585

    Article  CAS  PubMed  Google Scholar 

  26. Wolner-Hanssen P, Svensson L, Mardh PA, Westrom L (1985) Laparoscopic findings and contraceptive use in women with signs and symptoms suggestive of acute salpingitis. Obstet Gynecol 66(2):233–238

    CAS  PubMed  Google Scholar 

  27. Ness RB, Soper DE, Holley RL et al (2001) Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study. Am J Obstet Gynecol 185(1):121–127

    Article  CAS  PubMed  Google Scholar 

  28. Godfrey EM (2015) Helping clinicians prevent pregnancy among sexually active adolescents: U.S. medical eligibility criteria for contraceptive use and U.S. selected practice recommendations for contraceptive use. J Pediatr Adolesc Gynecol 28(4):209–214

    Article  PubMed  Google Scholar 

  29. Emans SJ, Grace E, Woods ER, Smith DE, Klein K, Merola J (1987) Adolescents’ compliance with the use of oral contraceptives. JAMA 257(24):3377–3381

    Article  CAS  PubMed  Google Scholar 

  30. Bagwell MA, Thompson SJ, Addy CL, Coker AL, Baker ER (1995) Primary infertility and oral contraceptive steroid use. Fertil Steril 63(6):1161–1166

    Article  CAS  PubMed  Google Scholar 

  31. Trussell J, Guthrie KA (2007) Talking straight about emergency contraception. J Fam Plann Reprod Health Care 33(3):139–142

    Article  PubMed  Google Scholar 

  32. Gemzell-Danielsson K (2010) Mechanism of action of emergency contraception. Contraception 82(5):404–409

    Article  CAS  PubMed  Google Scholar 

  33. Gemzell-Danielsson K, Berger C (2013) P GLL. Emergency contraception – mechanisms of action. Contraception 87(3):300–308

    Article  CAS  PubMed  Google Scholar 

  34. Cheng L, Che Y, Gulmezoglu AM (2012) Interventions for emergency contraception. Cochrane Database Syst Rev 8, CD001324

    Google Scholar 

  35. Emergency contraception. Faculty of sexual and reproductive healthcare clinical guidance. Jan 2012

    Google Scholar 

  36. (2015) Practice Bulletin No. 152: emergency contraception. Obstet Gynecol. 126(3):e1–e11

    Google Scholar 

  37. Kapp N, Abitbol JL, Mathe H et al (2015) Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception. Contraception 91(2):97–104

    Article  CAS  PubMed  Google Scholar 

  38. Levonorgestrel and ulipristal remain suitable emergency contraceptives for all women, regardless of bodyweight. European Medicines Agency. Press release 24/7/2014. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/07/news_detail_002145.jsp&mid=WC0b01ac058004d5c1ht

  39. Salcedo J, Rodriguez MI, Curtis KM, Kapp N (2013) When can a woman resume or initiate contraception after taking emergency contraceptive pills? A systematic review. Contraception 87(5):602–604

    Article  PubMed  Google Scholar 

  40. Ulipristal acetate. US FDA approved product information. National Library of Medicine

    Google Scholar 

  41. Clinical Effectiveness Unit (2011) Combined hormonal contraception. Faculty of Sexual and Reproductive Healthcare, London

    Google Scholar 

  42. Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, TACoO, Gynecologists (2012) Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol 120(4):983–988

    Article  Google Scholar 

  43. Ott MA, Sucato GS, Committee on Adolescents (2014) Contraception for adolescents. Pediatrics 134(4):e1257–e1281

    Article  PubMed  Google Scholar 

  44. Hubacher D, Goco N, Gonzalez B, Taylor D (1999) Factors affecting continuation rates of DMPA. Contraception 60(6):345–351

    Article  CAS  PubMed  Google Scholar 

  45. Logsdon S, Richards J, Omar HA (2004) Long-term evaluation of the use of the transdermal contraceptive patch in adolescents. ScientificWorldJournal 4:512–516

    Article  PubMed  Google Scholar 

  46. Rubinstein ML, Halpern-Felsher BL, Irwin CE Jr (2004) An evaluation of the use of the transdermal contraceptive patch in adolescents. J Adolesc Health 34(5):395–401

    Article  PubMed  Google Scholar 

  47. Zacur HA, Hedon B, Mansour D, Shangold GA, Fisher AC, Creasy GW (2002) Integrated summary of ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions. Fertil Steril 77(2 Suppl 2):S32–S35

    Article  PubMed  Google Scholar 

  48. Creasy GW, Abrams LS, Fisher AC (2001) Transdermal contraception. Semin Reprod Med 19(4):373–380

    Article  CAS  PubMed  Google Scholar 

  49. Stanwood NL, Garrett JM, Konrad TR (2002) Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practice. Obstet Gynecol 99(2):275–280

    PubMed  Google Scholar 

  50. American College of Obstetricians, Gynecologists Committee on Gynecologic Practice, Long-Acting Reversible Contraception Working Group (2009) ACOG Committee Opinion no. 450: increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstet Gynecol 114(6):1434–1438

    Article  Google Scholar 

  51. Teal SB, Romer SE, Goldthwaite LM, Peters MG, Kaplan DW, Sheeder J (2015) Insertion characteristics of intrauterine devices in adolescents and young women: success, ancillary measures, and complications. Am J Obstet Gynecol 213:515.e1–515.e5

    Article  Google Scholar 

  52. World Health Organization, Reproductive Health and Research (2010) Medical eligibility criteria for contraceptive use: a WHO family planning cornerstone, 4th edn. World Health Organization/Reproductive Health and Research, Geneva

    Google Scholar 

  53. Stanford JB, Mikolajczyk RT (2002) Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects. Am J Obstet Gynecol 187(6):1699–1708

    Article  PubMed  Google Scholar 

  54. Rozin S, Schwartz A, Schenker JG (1969) The mode of action of an intrauterine contraceptive device. Int J Fertil 14(2):174–179

    CAS  PubMed  Google Scholar 

  55. Rickert VI, Tiezzi L, Lipshutz J, Leon J, Vaughan RD, Westhoff C (2007) Depo now: preventing unintended pregnancies among adolescents and young adults. J Adolesc Health 40(1):22–28

    Article  PubMed  Google Scholar 

  56. Steiner MJ, Kwok C, Stanback J et al (2008) Injectable contraception: what should the longest interval be for reinjections? Contraception 77(6):410–414

    Article  CAS  PubMed  Google Scholar 

  57. Nelson AL, Katz T (2007) Initiation and continuation rates seen in 2-year experience with same day injections of DMPA. Contraception 75(2):84–87

    Article  CAS  PubMed  Google Scholar 

  58. Lei ZW, Wu SC, Garceau RJ et al (1996) Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception. Contraception 53(6):357–361

    Article  CAS  PubMed  Google Scholar 

  59. Canto De Cetina TE, Canto P, Ordonez Luna M (2001) Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate. Contraception 63(3):143–146

    Article  CAS  PubMed  Google Scholar 

  60. Westfall JM, Main DS, Barnard L (1996) Continuation rates among injectable contraceptive users. Fam Plann Perspect 28(6):275–277

    Article  CAS  PubMed  Google Scholar 

  61. Polaneczky M, Guarnaccia M, Alon J, Wiley J (1996) Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population. Fam Plann Perspect 28(4):174–178

    Article  CAS  PubMed  Google Scholar 

  62. Mulders TM, Dieben TO (2001) Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition. Fertil Steril 75(5):865–870

    Article  CAS  PubMed  Google Scholar 

  63. U.S. Selected Practice Recommendations for Contraceptive Use (2013): Adapted from the World Health Organization Selected Practice Recommendations for Contraceptive Use, 2nd Edition. Recommendations and Reports 62(RR05):1–46

    Google Scholar 

  64. Barreiros FA, Guazzelli CA, Barbosa R, de Assis F, de Araujo FF (2010) Extended regimens of the contraceptive vaginal ring: evaluation of clinical aspects. Contraception 81(3):223–225

    Article  CAS  PubMed  Google Scholar 

  65. Miller L, Verhoeven CH, Hout J (2005) Extended regimens of the contraceptive vaginal ring: a randomized trial. Obstet Gynecol 106(3):473–482

    Article  PubMed  Google Scholar 

  66. Barreiros FA, Guazzelli CA, de Araujo FF, Barbosa R (2007) Bleeding patterns of women using extended regimens of the contraceptive vaginal ring. Contraception 75(3):204–208

    Article  PubMed  Google Scholar 

  67. Guazzelli CA, Barreiros FA, Barbosa R, de Araujo FF, Moron AF (2009) Extended regimens of the vaginal contraceptive ring: cycle control. Contraception 80(5):430–435

    Article  PubMed  Google Scholar 

  68. Barreiros FA, Guazzelli CA, Barbosa R, Torloni MR, Barbieri M, Araujo FF (2011) Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism. Contraception 84(2):155–159

    Article  CAS  PubMed  Google Scholar 

  69. Polaneczky M, Slap G, Forke C, Rappaport A, Sondheimer S (1994) The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers. N Engl J Med 331(18):1201–1206

    Article  CAS  PubMed  Google Scholar 

  70. Lara-Torre E (2004) “Quick Start”, an innovative approach to the combination oral contraceptive pill in adolescents. Is it time to make the switch? J Pediatr Adolesc Gynecol 17(1):65–67

    Article  PubMed  Google Scholar 

  71. Coffee AL, Sulak PJ, Kuehl TJ (2007) Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception 75(6):444–449

    Article  PubMed  Google Scholar 

  72. Edelman A, Gallo MF, Nichols MD, Jensen JT, Schulz KF, Grimes DA (2006) Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials. Hum Reprod 21(3):573–578

    Article  CAS  PubMed  Google Scholar 

  73. Krashin J, Tang JH, Mody S, Lopez LM (2015) Hormonal and intrauterine methods for contraception for women aged 25 years and younger. Cochrane Database Syst Rev. (8):CD009805

    Google Scholar 

  74. Rosenstock JR, Peipert JF, Madden T, Zhao Q, Secura GM (2012) Continuation of reversible contraception in teenagers and young women. Obstet Gynecol 120(6):1298–1305

    Article  PubMed  PubMed Central  Google Scholar 

  75. Gold MA, Sucato GS, Conard LA, Hillard PJ, Society for Adolescent Medicine (2004) Provision of emergency contraception to adolescents. J Adolesc Health 35(1):67–70

    PubMed  Google Scholar 

  76. World Health Organization (WHO), Department of Reproductive Health and Research, Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP) (2011) Knowledge for health project. Family planning: a global handbook for providers (2011 update). CPP and WHO, Baltimore, Geneva

    Google Scholar 

  77. Trussell J (2011) Contraceptive failure in the United States. Contraception 83:397

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Hebrew University – Hadassah Medical Centre, Jerusalem, Israel

    Matan Elami-Suzin MD & Joseph G. Schenker MD, FRCOG, FACOG

Authors
  1. Matan Elami-Suzin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph G. Schenker MD, FRCOG, FACOG
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph G. Schenker MD, FRCOG, FACOG .

Editor information

Editors and Affiliations

  1. Département Hormonologie Hôpital Lapeyronie CHU et Université Montpellier, Unité d’Endocrinologie et Gynécologie Pédiatriques, Département de Pédiatrie Hôpital Arnaud-de-Villeneuve CHU et Université Montpellier, Montpellier, France

    Charles Sultan

  2. International Society of Gynecological Endocrinology, Pisa, Italy

    Andrea R. Genazzani

Rights and permissions

Reprints and permissions

Copyright information

© 2017 International Society of Gynecological Endocrinology

About this chapter

Cite this chapter

Elami-Suzin, M., Schenker, J.G. (2017). Adolescent Pregnancy and Contraception. In: Sultan, C., Genazzani, A. (eds) Frontiers in Gynecological Endocrinology. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-319-41433-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-41433-1_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-41431-7

  • Online ISBN: 978-3-319-41433-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation